Biotech · Private company
Morphotek
Track this companyFree. Adds Morphotek to your Dealase workspace and tells you when its record changes.
Clinical trials80 recruiting or active
Pipeline programs21From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline21
- CarboplatinPhase 3 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- FarletuzumabPhase 3 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- TaxanePhase 3 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- AmatuximabPhase 2 · Mesothelioma, MalignantClinicalTrials.gov · fetched Nov 12, 2026
- Best supportive carePhase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- CarboplatinPhase 2 · Adenocarcinoma of the LungClinicalTrials.gov · fetched Nov 12, 2026
- CisplatinPhase 2 · Mesothelioma, MalignantClinicalTrials.gov · fetched Nov 12, 2026
- CisplatinPhase 2 · Adenocarcinoma of the LungClinicalTrials.gov · fetched Nov 12, 2026
- CisplatinPhase 2 · Malignant Pleural MesotheliomaClinicalTrials.gov · fetched Nov 12, 2026
- DocetaxelPhase 2 · Metastatic Soft Tissue SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- FarletuzumabPhase 2 · Adenocarcinoma of the LungClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 2 · Metastatic Soft Tissue SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- MORAb-003Phase 2 · Epithelial Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- MORAb-004Phase 2 · Metastatic Soft Tissue SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- MORAb-004Phase 2 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
- MORAb-009 (Amatuximab)Phase 2 · Malignant Pleural MesotheliomaClinicalTrials.gov · fetched Nov 12, 2026
- PaclitaxelPhase 2 · Adenocarcinoma of the LungClinicalTrials.gov · fetched Nov 12, 2026
- PemetrexedPhase 2 · Adenocarcinoma of the LungClinicalTrials.gov · fetched Nov 12, 2026
- PemetrexedPhase 2 · Malignant Pleural MesotheliomaClinicalTrials.gov · fetched Nov 12, 2026
- PemetrexedPhase 2 · Mesothelioma, MalignantClinicalTrials.gov · fetched Nov 12, 2026
- MORAb-066Phase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM)PHASE2 · TERMINATED · started Nov 3, 2015ClinicalTrials.gov NCT02357147 · fetched Nov 12, 2026
- Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLCPHASE1 · COMPLETED · started Jun 19, 2013ClinicalTrials.gov NCT01761240 · fetched Nov 12, 2026
- Sarcoma Study of MORAb-004 Utilization: Research and Clinical EvaluationPHASE2 · COMPLETED · started Aug 7, 2012ClinicalTrials.gov NCT01574716 · fetched Nov 12, 2026
- Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)PHASE2 · TERMINATED · started Mar 27, 2012ClinicalTrials.gov NCT01507545 · fetched Nov 12, 2026
- A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the LungPHASE2 · COMPLETED · started Jun 27, 2011ClinicalTrials.gov NCT01218516 · fetched Nov 12, 2026
- An Open Label Extension Study of the Efficacy of MORAb-003PHASE2 · TERMINATED · started Jan 13, 2010ClinicalTrials.gov NCT01018563 · fetched Nov 12, 2026
- Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First RelapsePHASE3 · TERMINATED · started Apr 16, 2009ClinicalTrials.gov NCT00849667 · fetched Nov 12, 2026
- An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural MesotheliomaPHASE2 · COMPLETED · started Dec 31, 2008ClinicalTrials.gov NCT00738582 · fetched Nov 12, 2026